General anaesthesia with target controlled infusion of propofol and remifentanil for caesarean section

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004308

Enrollment

Unknown

Registered

2014-02-17

Start date

2013-03-12

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caesarean section

Interventions

A:remifentanil+Propofol for EC50 serum concentration + Rocuronium 0.6 mg/kg

B:remifentanil EC50 serum concentration, based on A group

Eligibility

Sex/Gender

Female

Age

19 Years to 40 Years

Inclusion criteria

Inclusion criteria: Over 36 gestational weeks,bsolute or relative contraindications to regional anesthesia: thrombopenia, spine malformation

Exclusion criteria

Exclusion criteria: Exact fetal distress, severe preeclampsia(SBP=160mmHg or DBP=110mmHg), cardiorespiratory diseases, neurological disease, known congeital abnormalities or signs of fetal compromise, and body height <152cm.

Design outcomes

Primary

Measure	Time frame
Blood presure;index of consciousness, IOC;Apgar score;	—

Countries

China

Contacts

Public ContactZhaohang Zhang

Qilu Hospital of Shandong University

zzh398@126.com+86 18560083826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026